MUMBAI, India, Sept. 14 -- Intellectual Property India has published a patent application (202611088112 A) filed by Chitkara University on July 19, 2026, for Targeted Nanoformulation Comprising Thymosin Alpha-1 And Phytochemicals For Immunomodulatory Management Of Rheumatoid Arthritis.
Inventors include Dr. Indu Bala; Dr. Pallavi Aggarwal; Dr. Mansi Chitkara; and Dr. Pranav Kumar Prabhakar.
The application for the patent was published on September 11, 2026, under issue no. 37/2026.
Abstract: The present invention relates to a targeted nanoformulation for immunomodulatory management of rheumatoid arthritis. The nanoformulation comprises a nanocarrier system incorporating Thymosin Alpha-1 and one or more phytochemicals selected from curcum...